Status | Study |
Not yet recruiting |
Study Name: Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) Condition: Medication-related Osteonecrosis of the Jaw Bisphosphonate-related Osteonecrosis of the Jaw Date: 2017-01-30 Interventions: Drug: Pentoxifylline Pentoxify |
Not yet recruiting |
Study Name: Medication-related Osteonecrosis of the Jaw (MRONJ) Registry Condition: Medication-related Osteonecrosis of the Jaw Bisphosphonate-Associated Date: 2016-10-12 Interventions: Procedure: Conservative treatment |
Completed |
Study Name: Performance Evaluation of the Micromedic BRONJ Risk Assessment in Vitro Diagnostic Assay Condition: Bisphosphonate-related Osteonecrosis of the Jaw Date: 2014-08-13 Interventions: Genetic: BRONJ collection of the blood sample from the subject for evaluation of the Micromedic BRONJ Ri |
Terminated |
Study Name: Prospective Randomized Study: Assessment of PRF Efficacy in Prevention of Jaw Osteonecrosis After Tooth Extraction Condition: Bisphosphonate-Associated Osteonecrosis of the Jaw Date: 2014-07-15 Interventions: Drug: tooth extraction with antibiotics (amoxicillin- clavulanate, clindamyc |
Withdrawn |
Study Name: Genetics in Predicting Risk of Bisphosphonate-Related Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid Condition: Malignant Neoplasm Musculoskeletal Complications Date: 2014-02-07 Interventions: Drug: zoledronic acid Given IV |
Completed |
Study Name: Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer Condition: Bone Diseases Metastases Osteonecrosis Date: 2011-03-28 |
Completed |
Study Name: Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis Condition: Osteonecrosis Date: 2008-01-14 Interventions: Other: Observational Group of patients with osteochemonecrosis related to oral bisphosphonate use |
Recruiting |
Study Name: Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use Condition: Date: 2024-03-28 |